Αρχική World News Treatment with Obecabtagene Autoleucel Results in Durable Response Among Adults with Relapsed... World News Treatment with Obecabtagene Autoleucel Results in Durable Response Among Adults with Relapsed or Refractory B-Cell ALL Από Ogkologos - 12 Δεκεμβρίου, 2024 970 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the FELIX study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Vulnerability in Brain Tumors May Open Door to New Treatments 26 Σεπτεμβρίου, 2022 7 images that defined cancer policy in 2022 27 Δεκεμβρίου, 2022 EMA Recommends Extending Indications for Durvalumab 17 Ιουλίου, 2025 A Clinical Signal of Efficacy Observed with a Combination of Nivolumab... 20 Ιουνίου, 2022 Φόρτωση περισσοτέρων HOT NEWS The US National COVID Cohort Collaborative Consortium Provides Real-World Evidence on... How to Maintain Your Sexual Health During and After Lung Cancer Breast cancer surgery: ‘I’m proud of the tattoos inked across my... Blood Test Accurately Detects Early-Stage Pancreatic Cancer